ALAINA LOPP: Open Payments
NPI 1629700182 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 27 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $349 · 2025 $707
Food & beverage: $608Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $113 |
| Gilead Sciences, Inc. | 1 | $93 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Exelixis Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $30 |
| Deciphera Pharmaceuticals Inc. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Eisai Inc. | 1 | $24 |
Products named: Trodelvy, KISQALI, KEYTRUDA, CABOMETYX, BRUKINSA, VENCLEXTA, QINLOCK, ULTOMIRIS.
Industry payments across MI — which companies pay providers there.
